<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/pharmacists-lipoprotein-a-testing-cardiovascular-risk-management</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T14:10:49.195Z</news:publication_date>
      <news:title>Pharmacists Take Lead Role in Lp(a) Testing, Cardiovascular Prevention</news:title>
      <news:keywords>cardiovascular, lipoprotein(a), pharmacist-clinical-role, statin-adherence, preventive-cardiology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-warning-letters-hangover-supplement-companies-illegal-claims</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-04T14:10:49.115Z</news:publication_date>
      <news:title>FDA Targets Hangover Supplement Makers in Marketing Claims Crackdown</news:title>
      <news:keywords>FDA, warning-letters, hangover-supplements, marketing-claims, enforcement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/novo-nordisk-korro-bio-rna-editing-deal-530-million</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-04T08:47:02.601Z</news:publication_date>
      <news:title>Novo Nordisk Commits $530M to RNA Editing in Korro Bio Deal</news:title>
      <news:keywords>RNA editing, Novo Nordisk, Korro Bio, gene therapy, precision medicine</news:keywords>
    </news:news>
  </url>
</urlset>